GlassScriptPhysician profile
Debbie A Saiovici
NPI 1205305778
$1,167.07
in general payments reported to CMS, 2019-2025
12 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $238 · 2022: $415 · 2023: $90.91 · 2024: $132 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $372.03 | 2021-2025 | |
| Stryker Corporation | $252.22 | 2021-2025 | Audion Et Dilation System |
| Glaxosmithkline, LLC. | $148.42 | 2023-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $134.57 | 2022 | |
| Genzyme Corporation | $108.32 | 2022 | |
| Hikma Pharmaceuticals USA | $32.44 | 2023-2024 | Ryaltris |
| Integra Lifesciences Corporation | $29.83 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Phathom Pharmaceuticals, INC. | $22.27 | 2025 | Voquezna |
| Medtronic, INC. | $19.78 | 2024 | Sinuva |
| Kaleo, INC. | $16.74 | 2021 | |
| Lilly USA, LLC | $16.26 | 2025 | Mounjaro |
| Paratek Pharmaceuticals, INC. | $14.19 | 2025 | Xhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debbie Saiovici listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.